BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24710430)

  • 1. CT and MR image fusion of tandem and ring applicator using rigid registration in intracavitary brachytherapy planning.
    Oinam AS; Tomar P; Patel FD; Singh L; Rai B; Bahl A
    J Appl Clin Med Phys; 2014 Mar; 15(2):4206. PubMed ID: 24710430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of an electromagnetic tracking enabled afterloader based on the automated registration with CT phantom images.
    Gomez-Sarmiento IN; Tho D; Dürrbeck C; de Jager W; Laurendeau D; Beaulieu L
    Med Phys; 2024 Feb; 51(2):799-808. PubMed ID: 38127342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
    Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
    Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Techniques for and uncertainties of MRI-based reconstruction of titanium tandem and ring brachytherapy applicators.
    Malajovich I; Anamalayil S; Dolney OV; Kevin Teo BK; Arscott WT; Taunk NK
    Brachytherapy; 2020; 19(5):651-658. PubMed ID: 32624406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
    Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
    Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of fusing three-dimensional transabdominal and transrectal ultrasound images for comprehensive intraoperative visualization of gynecologic brachytherapy applicators.
    Rodgers JR; Mendez LC; Hoover DA; Bax J; D'Souza D; Fenster A
    Med Phys; 2021 Oct; 48(10):5611-5623. PubMed ID: 34415069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of Intracavitary Applicator Placement for HDR Brachytherapy of Cervix Cancer.
    Balsdon A; Timotin E; Hunter R; Diamond K
    J Med Imaging Radiat Sci; 2019 Sep; 50(3):441-448. PubMed ID: 31311722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
    Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
    Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
    Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
    Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer.
    Haack S; Nielsen SK; Lindegaard JC; Gelineck J; Tanderup K
    Radiother Oncol; 2009 May; 91(2):187-93. PubMed ID: 18977049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method to assess the need for re-planning HDR brachytherapy tandem and ring treatments.
    Gray T; Cherian S; Amarnath S; Guo B; Xia P; Wilkinson A
    Med Dosim; 2024 Apr; ():. PubMed ID: 38616141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining transrectal ultrasound and CT for image-guided adaptive brachytherapy of cervical cancer: Proof of concept.
    Nesvacil N; Schmid MP; Pötter R; Kronreif G; Kirisits C
    Brachytherapy; 2016; 15(6):839-844. PubMed ID: 27693172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localizing intracavitary brachytherapy applicators from cone-beam CT x-ray projections via a novel iterative forward projection matching algorithm.
    Pokhrel D; Murphy MJ; Todor DA; Weiss E; Williamson JF
    Med Phys; 2011 Feb; 38(2):1070-80. PubMed ID: 21452744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
    Han DY; Safigholi H; Soliman A; Ravi A; Leung E; Scanderbeg DJ; Liu Z; Owrangi A; Song WY
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):440-448. PubMed ID: 27598809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer.
    De Leeuw AA; Moerland MA; Nomden C; Tersteeg RH; Roesink JM; Jürgenliemk-Schulz IM
    Radiother Oncol; 2009 Nov; 93(2):341-6. PubMed ID: 19515443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an active magnetic resonance tracking system for interstitial brachytherapy.
    Wang W; Viswanathan AN; Damato AL; Chen Y; Tse Z; Pan L; Tokuda J; Seethamraju RT; Dumoulin CL; Schmidt EJ; Cormack RA
    Med Phys; 2015 Dec; 42(12):7114-21. PubMed ID: 26632065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of uterus position as a surrogate for high-risk clinical target volume with respect to the applicator position for multiple fractions of brachytherapy in cervical cancer.
    Cooper R; Brearley E; Hurmuz P; Musunuru HB; Richardson C; Swift S; Orton J; Bownes P
    Arch Gynecol Obstet; 2014 Dec; 290(6):1201-5. PubMed ID: 25001571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.